Innovation Pharmaceuticals Inc (IPIX)

[frrol]

Having just watched the response rates from interim to final B OM data turn from superb to good, it makes one very cautious indeed about prurisol.

Yes, and this is one of the typical and too often unacknowledged risks in biotech by inexperienced retail investors.

I predict that the prurisol data will not come out until there is a B deal announced beforehand, unless the P results are very good.

The two are not linked. Management will announce P results when the results are ready, which is how they always do it. They might want to wait for a scientific conference to do it, but that is unlikely as they have given no intention of such. But a B deal is certainly not the milestone. It is irrelevant.